| Symbol | CARL |
|---|---|
| Name | CARLSMED, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 1800 ASTON AVE,SUITE 100, CARLSBAD, California, 92008, United States |
| Telephone | 858-295-9290 |
| Fax | — |
| — | |
| Website | https://carlsmed.com/ |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001794546 |
| Description | Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. We are focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of artificial intelligence-enabled software solutions, and interbody implants that we custom design for each patients unique pathology and vertebral bone topography, and single-use surgical instruments (the "aprevo Technology Platform"). The aprevo Technology Platform was designed to address the limitations of traditional spine fusion surgery and aims to optimize patient outcomes and reduce the need for revision surgeries. Additional info from NASDAQ: |
Bertolini Jeffrey 🟢 acquired 50.0K shares (1 derivative) of CARLSMED, INC. (CARL) at $15.23 Transaction Date: Sep 08, 2026 | Filing ID: 000005
Read moreNew Form 3 - CARLSMED, INC. <b>Filed:</b> 2026-09-10 <b>AccNo:</b> 0002147819-26-000004 <b>Size:</b> 19 KB
Read moreNew Form EFFECT - CARLSMED, INC. <b>Filed:</b> 2026-08-21 <b>AccNo:</b> 9999999995-26-002735 <b>Size:</b> 1 KB
Read moreNew Form S-3 - CARLSMED, INC. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-352226 <b>Size:</b> 1 MB
Read moreCarlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
Read moreCarlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
Read more